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Lead perforation is a major complication of cardiac rhythm management devices (CRMD), occurring in about 1%. While most
lead perforations occur early, numerous instances of delayed lead perforation (occurring >30 days after implantation) have
been reported in the last few years. Only about 40 such cases have been published, with the majority occurring <1 year after
implantation. Herein, we describe the case of an 84-year-old female who presented with recurrent syncope and was diagnosed to
have delayed pacemaker lead perforation 4.8 years after implantation. Through this report, we intend to highlight the increasing
use of CRMD in elderly patients, and the lifelong risk of complications with these devices. Presentation can be atypical and a high
index of suspicion is necessary for diagnosis.
1.Introduction
Increasing burden of cardiovascular disease and broadening
indications have led to a signiﬁcant increase in the implan-
tation of cardiac rhythm management devices (CRMDs)
[1–3]. Approximately 70% of CRMD recipients are ≥65
years of age and 20%–35% are older than 80 years [1–
4]. Cardiac perforation is a major complication of CRMD
implantation and can be acute, subacute, or delayed. Herein,
we describe a case of delayed pacemaker lead perforation
(DLP) occurring 4.8 years after implantation. Through this
report, we emphasize the need to consider device related
complications in the diﬀerential diagnoses of patients with
CRMD, even years after implantation.
2.CaseSummary
An 84-year-old female presented with two episodes of tran-
sient loss of consciousness over 24 hours. She was initially
evaluated in the emergency room of an outlying hospital
where physical examination, electrocardiogram (ECG), and
chest X-ray were unremarkable. Subsequently, she was trans-
ferredtoourhospitalforfurtherevaluation.Shedeniedchest
pain, palpitations, dyspnea, or orthostatic dizziness. She was
seated at the time of the index events, had no premonitory
symptoms,andregainedconsciousnesswithinafewminutes.
Past medical history was signiﬁcant for rheumatoid arthritis,
paroxysmal atrial ﬁbrillation, and symptomatic sinus pauses
requiring a dual chamber pacemaker placement. The pace-
maker (Medtronic, KDR901 Kappa DR; leads: Medtronic
5076 CapSure Fix Novus) was implanted in December,
2004 with the right ventricular lead in the apex and right
atrial lead in the appendage. Her medications included
warfarin, metoprolol, prednisone, and amiodarone. Pulse
rate was 65/minute, blood pressure was 96/58mmHg, and
physical examination was signiﬁcant for prominent jugular
venouspulsations,anddistantheartsounds.Metabolicpanel
and blood counts were normal and INR was therapeutic
at 2.1. ECG revealed normal sinus rhythm without any
abnormalities, chest X-ray demonstrated mild cardiomegaly
with stable atrial/ventricular lead position and computed
tomography scan of the head was unremarkable. Transtho-
racic echocardiogram revealed a large pericardial eﬀusion
with early echocardiographic signs of cardiac tamponade
(Figure 1 ). Pacemaker evaluation revealed normal function;
lead impedance, sensing and pacing thresholds were stable
compared to evaluation 3 months prior. Previous echocar-
diogram, also done 3 months prior was unremarkable2 Cardiology Research and Practice
Table 1: Previously published cases of delayed lead perforation showing patient age and the delay from implantation to perforation.
Author Publication Number of patients Age in years
Time from
implantation to
perforation
Comments
Ahmet Akyol
Pacing Clin
Electrophysiol 2005;
28:350–351
1 24 6 months
Khan MN
Pacing Clin
Electrophysiol 2005;
28:251–253
3 26, 71, 81 6–10 months
Velavan P Heart 2003; 89:364 1 64 1 month
Satpathy R
Pacing Clin
Electrophysiol 2008;
31:10–12
17 2 1 0 m o n t h s
Haq SA Angiology 2008;
59:619 18 6 1 6 m o n t h s
Ellenbogen KA
Pacing Clin
Electrophysiol 2002;
25:1155–1158
3 73, 72, 42 30 days
3/5 cases reported
here were late
perforations others
being sub acute.
Kautzner J
Pacing Clin
Electrophysiol 2001;
24:116–118
13 6 2 3 m o n t h s
Symptoms of
pericarditis
without
perforation 4
months after
implantation.
Polin GM Am J Cardiol. 2006
15; 98:223–5 5 38, 55, 79, 85, 88 6 weeks–3years
Laborderie J Am J Cardiol 2008;
102:1352–1355 8 35, 50, 40, 53, 64,
78, 81, 84 1–3.5 months
8/11 cases reported
here were late
perforations.
Fisher JD
Pacing Clin
Electrophysiol 2008;
31:7–9
17 1 3 8 d a y s
Krivan L
Pacing Clin
Electrophysiol 2008;
31:3–6
1 47 1 month
1/2 cases reported
here was late
perforation the
other was acute.
Lloyd MS
Pacing Clin
Electrophysiol 2008;
31:784–785
16 8 6 w e e k s
1/3 cases reported
here was late
perforation others
being sub acute.
Suri R Heart Rhythm. 2007
Sep; 4(9):1248–9 1N A 6 w e e k s
1/5 cases reported
here was late
perforation others
being sub acute.
Sadamatsu K J Cardiol. 2009;
53(1):150–3. 1 NA 9 months asymptomatic
Kanoh M Kyobu Geka. 1994;
47:730–1 1 80 3 months asymptomatic
Park RE
Pacing Clin
Electrophysiol 2008;
31:785–786
17 2 6 w e e k s
Singhal S Circulation. 2007;
115:e391-2 1 50 7 years Perforated through
the rib.
Wiegand UK
Pacing Clin
Electrophysiol. 2003;
26(10):1961-9
1 NA 3 years
1 case of delayed
p e r f o r a t i o ni n1 1 6
implanted leads.Cardiology Research and Practice 3
Table 1: Continued.
Author Publication Number of patients Age in years
Time from
implantation to
perforation
Comments
Sanoussi A
Pacing Clin
Electrophysiol. 2005;
28:723–725
1 79 1 month
Tziakas D Europace 2009;
11:968–969. 18 4 5 w e e k s
Celik T Europace 2009;
11:963–965. 2 73, 65 8 months, 2 years
Tavernier R Europace. 2009;
11:966–7 1 74 1 month
M I:1 . 5
S3
Creighton UNIV.
Cardiac center
CU echo
0 : 39 : 24
GAIN 56
COMP 70
19cm
45Hz
T
P R
1.6 3.2
PCE
LV
RV
73BPM
Figure 1: Transthoracic echocardiogram in parasternal long axis
view showing the large pericardial eﬀusion. LV: left ventricle; RV:
right ventricle; PCE: pericardial eﬀusion.
except for mild left ventricular hypertrophy. She underwent
emergent surgical pericardiocentesis and about 600mL of
bloody ﬂuid was drained. During the surgery, a defect
in the right ventricular myocardium was visualized and
repaired with sutures. The ventricular lead was in close
proximity but there was no deﬁnite protrusion of the tip
through the defect. A pericardial window was created and
therightventricularleadwassuccessfullyrepositionedunder
transesophageal echo guidance. Pericardial ﬂuid cultures
were sterile, cytology was negative for malignant cells, and
pericardial biopsy was normal. Further hospital stay was
uneventful and she was discharged on her home medication
regimen. She has had no recurrent symptoms or pericardial
eﬀusion at 1 year followup.
3. Discussion
The frequency of lead perforation varies between 0.1%–
0.8% for pacemaker leads and 0.6%–5.2% for deﬁbrillators
[5–7]. Lead perforation is considered to be acute when it
occurs within 5–7 days after implantation; subacute when it
occurs between 7–30 days; delayed when it occurs beyond
30 days after implantation. While most lead perforations
occur early, DLP has been increasingly reported in the last
few years. We identiﬁed a total of 38 patients with DLP in
our review of literature (Table 1). The vast majority of these
occurred between 6 weeks and 1 year from implantation;
7/38 patients had DLP beyond one year and only one patient
had this complication >3 years after implantation. Our
patient presented close to 5 years after implantation, which
is unusually long and underscores the potential lifelong
risk.
Though the lead was not visualized in the pericardial
space we believe that DLP is the most likely explanation in
our patient. The lead was noted to be in close proximity to
the defect in the RV myocardium, eﬀusion was bloody, and
there was no alternative etiology for myocardial perforation
or pericardial eﬀusion. However, the exact timing of lead
perforation is unclear. Though chronic perforation cannot
deﬁnitively be excluded, a normal echocardiogram 3 months
prior suggests that this was more recent. Presentation of
DLP is variable ranging from minimal or no symptoms
to cardiac tamponade and sudden death. Several known
risk factors for acute lead perforation exist; these include
patient characteristics like advanced age, female gender;
hardware factors like deﬁbrillator versus pacemaker leads,
smaller lead diameter, increased lead stiﬀness, active versus
passive
ﬁxationtips;andmiscellaneousfactorslikeuseofsteroids
in the perioperative period [8]. However, the role of these
factors in DLP has not been clearly established.
Insummary,patientscontinuetobeatriskforpotentially
grave complications like lead perforation many years after
implantation of CRMD. Symptoms can be subtle or atypical
especially in those with advanced age and a high index of
suspicion is necessary for timely diagnosis.
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